These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 2931845)

  • 1. [Clinical effectiveness of the method of extracorporeal heparin precipitation of plasma proteins (selective plasmapheresis) in patients with immune complex pathology].
    Margulis EIa; Savchenko VG; Vasil'ev SA; Gorodetskiĭ VM; Ryzhko VV
    Ter Arkh; 1985; 57(7):125-31. PubMed ID: 2931845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of the method of extracorporeal heparin precipitation of plasma proteins (selective plasmapheresis) on the level of immune complexes in the blood].
    Savchenko VG; Margulis EIa; Vasiliev SA; Gorodetskiĭ VM; Ryzhko VV
    Ter Arkh; 1985; 57(7):102-7. PubMed ID: 2931844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The results of 5 years' use of a method for heparin cryoprecipitation of plasma proteins (selective plasmapheresis) in patients with an immune-complex pathology].
    Margulis EIa; Savchenko VG
    Ter Arkh; 1989; 61(7):65-9. PubMed ID: 2531473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of cryoapheresis on the course of immune complex diseases].
    Margulis EIa; Savchenko VG; Zherdeva LV; Tolkachev AA; Selezneva OM
    Ter Arkh; 1987; 59(6):80-5. PubMed ID: 2957815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Changes in fibronectin concentration during therapeutic plasmapheresis. Therapeutic effectiveness of selective removal of fibronectin in immune complex pathology].
    Vasil'ev SA; Savchenko VG; Gorodetskiĭ VM; Ermolin GA; Kotelianskiĭ VE
    Ter Arkh; 1984; 56(6):35-9. PubMed ID: 6236575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Plasmapheresis in the treatment of diseases caused by immunologic pathology].
    Gorodetskiĭ VM; Ryzhko VV
    Ter Arkh; 1984; 56(6):19-23. PubMed ID: 6236574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Apheresis of euglobulins, cryoglobulins and the von Willebrand factor in vasculitis].
    Savchenko VG; Iakhnina EI; Margulis EIa; Shklovskii-Kordi NE; Kuznetsov AI
    Ter Arkh; 1987; 59(6):75-9. PubMed ID: 2957814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes in the plasma coagulation factors in patients subjected to plasmapheresis].
    Doĭchinov A; Shtereva T; Bŭchvarova V; Khristova V; Mikhalev A
    Vutr Boles; 1986; 25(2):68-72. PubMed ID: 3716381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmapheresis in rapidly progressive Henoch-Schoenlein glomerulonephritis and the effect on circulating IgA immune complexes.
    Kauffmann RH; Houwert DA
    Clin Nephrol; 1981 Sep; 16(3):155-60. PubMed ID: 7296974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fibronectin and immune complexes in rheumatic diseases].
    Mazepa MA
    Vestn Akad Med Nauk SSSR; 1991; (4):57-61. PubMed ID: 1830993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of immunologic diseases using plasma separation. Proven and unproved indications].
    Schranz W; Kalden JR
    Fortschr Med; 1984 Apr; 102(16):458-62. PubMed ID: 6233210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A positive effect of combined therapy (plasmapheresis in combination with pulse therapy) on the course of cryoglobulinemic glomerulonephritis and ulcerative-necrotic vasculitis in patients with Sjögren's disease].
    Vasil'ev VI; Solov'ev SK; Chiklikchi AS; Kirtava ZZ; Mach ES
    Ter Arkh; 1987; 59(11):54-9. PubMed ID: 3441866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Plasma- and lymphapheresis in autoimmune diseases].
    Schneider M
    Z Rheumatol; 1996; 55(2):90-104. PubMed ID: 8686387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Life-threatening or organ-impairing Henoch-Schönlein purpura: plasmapheresis may save lives and limit organ damage.
    Donghi D; Schanz U; Sahrbacher U; Recher M; Trüeb RM; Müllhaupt B; French LE; Hafner J
    Dermatology; 2009; 219(2):167-70. PubMed ID: 19494483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The use of plasmapheresis in treating Sjögren's disease (syndrome)].
    Gubin MA; Shcherbachenko OI; Lobodov BV
    Stomatologiia (Mosk); 1996; 75(3):24-6. PubMed ID: 9036579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic plasma exchange: indications and results].
    Roujeau JC; Quaranta JF; Guillevin L; Cassuto JP; Chalopin JM; Gajdos P; Sobel A; Rifle G
    Ann Med Interne (Paris); 1984; 135(4):308-27. PubMed ID: 6236729
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasmapheresis in patients with leukaemia, multiple myeloma and immune complex diseases.
    Mód A; Füst G; Harsányi V; Natonek K; Poros A; Szabó J; Hollán SR
    Haematologia (Budap); 1981; 14(1):49-56. PubMed ID: 6454615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short and longterm experience with plasmapheresis in connective tissue diseases.
    Dequeker J; Geusens P; Wielands L
    Biomedicine; 1980 Dec; 32(4):189-94. PubMed ID: 7470581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative assessment of various programs of plasmapheresis in the combined treatment of patients with rheumatoid arthritis].
    Talybov FIu; Dubrovina NA; Kalinin NN; Petrova VI; Movshev BE
    Klin Med (Mosk); 1992 Feb; 70(2):51-4. PubMed ID: 1507822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic plasmapheresis in immune complex diseases].
    Movshev BE; Kalinin NN; Petrova VI
    Ter Arkh; 1994; 66(7):70-3. PubMed ID: 7985137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.